352 related articles for article (PubMed ID: 23147197)
21. JARID1 Histone Demethylases: Emerging Targets in Cancer.
Harmeyer KM; Facompre ND; Herlyn M; Basu D
Trends Cancer; 2017 Oct; 3(10):713-725. PubMed ID: 28958389
[TBL] [Abstract][Full Text] [Related]
22. The MYC-WDR5 Nexus and Cancer.
Thomas LR; Foshage AM; Weissmiller AM; Tansey WP
Cancer Res; 2015 Oct; 75(19):4012-5. PubMed ID: 26383167
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional Regulation of mPGES1 in Cancer: An Alternative Approach to Drug Discovery?
Ramanan M; Doble M
Curr Drug Targets; 2017; 18(1):119-131. PubMed ID: 27570080
[TBL] [Abstract][Full Text] [Related]
24. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins MA; Huang M; Zhao R
Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
[TBL] [Abstract][Full Text] [Related]
25. [Histone deacetylase inhibitors - molecular mechanisms of actions and clinical applications].
Grabarska A; Dmoszyńska-Graniczka M; Nowosadzka E; Stepulak A
Postepy Hig Med Dosw (Online); 2013 Aug; 67():722-35. PubMed ID: 24018438
[TBL] [Abstract][Full Text] [Related]
26. Rewiring the solid tumor epigenome for cancer therapy.
Braun CJ; Hemann MT
Expert Rev Anticancer Ther; 2016 Sep; 16(9):977-87. PubMed ID: 27410491
[TBL] [Abstract][Full Text] [Related]
27. How cancer cells remodel lipid metabolism: strategies targeting transcription factors.
Jeong DW; Lee S; Chun YS
Lipids Health Dis; 2021 Nov; 20(1):163. PubMed ID: 34775964
[TBL] [Abstract][Full Text] [Related]
28. Mapping the Pathways of Resistance to Targeted Therapies.
Wood KC
Cancer Res; 2015 Oct; 75(20):4247-51. PubMed ID: 26392071
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of acquired resistance to targeted cancer therapies.
Lackner MR; Wilson TR; Settleman J
Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
[TBL] [Abstract][Full Text] [Related]
30. The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy.
Dias MH; Papagianni C; Bernards R
Cancer Cell; 2024 Jun; 42(6):919-922. PubMed ID: 38788721
[TBL] [Abstract][Full Text] [Related]
31. Direct inhibition of RAS: Quest for the Holy Grail?
Spencer-Smith R; O'Bryan JP
Semin Cancer Biol; 2019 Feb; 54():138-148. PubMed ID: 29248537
[TBL] [Abstract][Full Text] [Related]
32. Editorial overview: cancer: from target discovery to targeted therapy: the risky business of target validation.
Cruzalegui F
Curr Opin Pharmacol; 2014 Aug; 17():iv-vi. PubMed ID: 25220882
[No Abstract] [Full Text] [Related]
33. Transcription factors and chromatin proteins as therapeutic targets in cancer.
Johnston SJ; Carroll JS
Biochim Biophys Acta; 2015 Apr; 1855(2):183-92. PubMed ID: 25721328
[TBL] [Abstract][Full Text] [Related]
34. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
35. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
36. Drugging the 'undruggable' cancer targets.
Dang CV; Reddy EP; Shokat KM; Soucek L
Nat Rev Cancer; 2017 Aug; 17(8):502-508. PubMed ID: 28643779
[TBL] [Abstract][Full Text] [Related]
37. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.
Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):167-70. PubMed ID: 9593058
[No Abstract] [Full Text] [Related]
38. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
39. Signal transduction pathways and transcriptional mechanisms as targets for prevention of emergence of multidrug resistance in human cancer cells.
Shtil AA
Curr Drug Targets; 2001 Mar; 2(1):57-77. PubMed ID: 11465539
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
